Clinical trial
A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes
NCT00401583 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00401583 |
|---|---|
| Title | A Study To Test The Effect Of GW786034 (Pazopanib) On P450 Enzymes |
| Official title | A Multi-center, Open-Label, Multiple-probe Drug Interaction Study to Determine the Effects of GW786034 on the Metabolism of Cytochrome P450 Probe Drugs in Patients With Solid Tumors |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma, Renal Cell |
| Intervention type | Drug |
| Interventions | GW786034 (pazopanib), Probe drugs |
| Enrollment | 24 |
| Start date | Jul 28, 2006 |
| Primary completion | Feb 20, 2008 |
| Completion | Feb 20, 2008 |
| First posted | Nov 20, 2006 |
| Last update posted | Nov 13, 2017 |
| Countries | Singapore, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: